Monday, April 10, 2017

'The Green Room' Set For A Smokey Youtube Premiere On April 20

'The Green Room' Set For A Smokey Youtube Premiere On April 20


Los Angeles - April 10, 2017 (Investorideas.com Newswire) Have you ever wondered what goes on behind the counter in a medical marijuana dispensary? Dancing Silly Productions is unveiling a groundbreaking new comedy series about the antics and lives of six characters working in a failing medical marijuana dispensary called THE GREEN ROOM. Set in the heart of Hollywood, viewers will get a real-world peak into a dispensary in the fictional tale of these budtenders.
Award-winning indie filmmakers Lizz Henderson and Rich Sturdevant were inspired to create THE GREEN ROOM after many questions from friends and family members back in their native New York town about medical marijuana. "We wanted to answer questions about what it was like to live in a state that allows for legal medical marijuana, spread the word on the actual positive medical benefits of it, and make people laugh" said Executive Producer Lizz Henderson. Both Henderson and Sturdevant embarked on the web series through their Dancing Silly Productions company; additional producers are Zahida Kazar and Jon Allyn.
"The Green Room" is dedicated to breaking myths surrounding marijuana and educating those unfamiliar with the plant and its myriad of positive properties in every episode. With a hilarious cast of up and coming actors and comedians, it will premiere on YouTube on April 20th. The series creators and selected cast are available for interviews.
THE GREEN ROOM Trailer: http://bit.ly/2oOWrh0
Connect with THE GREEN ROOM:
ABOUT DANCING SILLY PRODUCTIONS
Dancing Silly Productions is an independent film production company based in Hollywood, CA., founded eight years ago by husband and wife super duo, Rich & Lizz. The pair has a passion for filmmaking and have created dozens of short films over the past several years, including "No Sugar Rim" and "The Walker." Their first feature-length film, Suicide is Easy, was released in 2008 and won Best Guerrilla Film at the Action on Film International Film Festival in 2009. Their second feature, Envisage, was acquired by indie distributor Gravitas Ventures and will be available internationally on digital and cable VOD. To learn more, please visit http://dancingsillyproductions.com.
Media Inquiries
Zahida Kazar: zahidakazar@gmail.com
Elizabeth Henderson: elzhenderson@yahoo.com


Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks




Watch the 420 Cannabis Investor video

 

 More Info:



This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Posted by at No comments:

#Cannabis Stock News: Organigram (TSX VENTURE: $OGI) (OTCQB: $OGRMF) Enters into LOI to Acquire Trauma Healing Centers

#Cannabis Stock News: Organigram (TSX VENTURE: $OGI) (OTCQB: $OGRMF) Enters into LOI to Acquire Trauma Healing Centers


MONCTON, NEW BRUNSWICK - April 10, 2017 (Investorideas.com Newswire) Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) ("Organigram" or the "Company") is pleased to announce that it has entered into a letter of intent (the "LOI") to acquire (the "Transaction") all of the issued and outstanding shares of Trauma Healing Centers Incorporated ("THC").
"Organigram and THC have enjoyed a close working relationship over the past two years, and we have great mutual respect for each other's business," said Greg Engel, CEO of Organigram. "THC's commitment to client care, specifically within the veteran community, is aligned with our client care commitment as part of our Canada's Safest Cannabis initiatives," added Engel. "We also believe this arrangement allows both companies the resources to scale up and achieve our future expansion plans."
Trauma Healing Centers, which is celebrating its second anniversary, specializes in medical cannabis assessment and prescribing. THC sees patients on a referral basis and offers a multi-disciplinary approach to healing chronic conditions. Trauma Healing Centers is the only organization to boast a multi-disciplinary designation with Blue Cross for military and RCMP veteran clients. THC currently services over 3,500 patients across seven Canadian locations with plans to open seven more locations.
The Transaction will result in THC joining the Organigram group thereby consolidating two leading medicinal cannabis players within the industry. THC will continue to operate independently by providing referrals based on client need to any licensed producer in Canada.
"We are pleased to be joining the Organigram family," stated Kyle Atkinson, President of Trauma Healing Centers. "They have established themselves as a leading medical cannabis producer in Canada and we look forward to a long, rewarding relationship."
Under the terms of the LOI, the purchase consideration consists of the issuance of 719,425 common shares of Organigram at a deemed value of $2.78 per share.
The closing of the Transaction is subject to customary closing conditions, including execution of definitive documentation, completion of satisfactory due diligence and receipt of applicable third party and regulatory approvals, including that of the TSX Venture Exchange.
For more information about Trauma Healing Centers visit www.traumahc.com.
For more information visit www.organigram.ca.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations ("ACMPR").
In February 2017, Organigram was ranked in the top ten Clean Technology & Life Sciences Sector on the TSX Venture Exchange 50.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact Information
Organigram Holdings Inc.
Greg Engel
Chief Executive Officer
gengel@Organigram.ca
Organigram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986
www.organigram.ca


More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Posted by at No comments:

Cannabis Stock News: Supreme Pharmaceuticals (CSE: $SL) Announces Conditional Approval to List on the TSX.V

Cannabis Stock News: Supreme Pharmaceuticals (CSE: $SL) Announces Conditional Approval to List on the TSX.V

TORONTO, ONTARIO - April 10, 2017 (Investorideas.com Newswire) Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (CSE:SL)(CSE:SL.CN) is pleased to announce that it has received conditional approval from the TSX Venture Exchange ("TSX.V") to list the Company's common shares on the TSX.V.
John Fowler, President and CEO, stated: "Graduating from the CSE to the TSX.V is an important milestone for Supreme. We enjoyed tremendous success throughout our time on the CSE, which provided us the flexibility we needed in the early stages of our growth. Graduating to the TSX.V prepares us for the next steps in the development of our cannabis business."
The Company would like to thank the CSE for its role in Supreme's success over the past three years.
Final approval of listing on the TSX.V is subject to Supreme satisfying certain customary conditions required by the TSX.V. Supreme expects that it will be able to satisfy all such conditions by mid-May 2017 and will provide an update once the TSX.V has issued a bulletin confirming the date on which trading on the TSX.V will commence. Following completion of all listing requirements, Supreme's common shares will be voluntarily delisted from the Canadian Securities Exchange and will begin trading on the TSX.V under a new symbol.
About Supreme
Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations operating inside a 342,000 sq. ft. Hybrid Greenhouse facility. The Hybrid Greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit www.supreme.ca and www.7acres.com for more information.
Cautionary Note Regarding Forward Looking Statements
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in the Company's periodic filings with Canadian securities regulators. Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, other factors could cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; timing for completion of TSX.V approval; limited operating history; competition; inconsistent public opinion and perception of the medical-use marijuana industry; and regulatory or political change. There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. The Company disclaims any intention or obligation to update or revise such information, except as required by applicable law.
Neither Canadian Securities Exchange nor the TSX Venture Exchange has reviewed, approved or disapproved the content of this news release.
Contact Information
Investor Relations
202 - 20 De Boers Dr
Toronto ON M3J 0H1
(416) 630-7272
info@supreme.ca
www.supreme.ca


More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Posted by at No comments:

Cannabis and Hemp Stock Directory Featuring Canadian, US and Global Stocks now Available in PDF

Cannabis and Hemp Stock Directory Featuring Canadian, US and Global Stocks now Available in PDF

Point Roberts, WA, Delta BC - April 10, 2017 - Investorideas.com, a global news source and investor resource covering actively traded sectors announces the cannabis /hemp stock directory for investors following the sector is now available for purchase in a PDF format.

The directory, which features Canadian listed, US listed and global cannabis stocks is available to Investors as part of the annual membership or in a downloadable PDF.
Following recent news of the intention of the Canadian Government to legalize marijuana on a Federal level by July 1, 2018, Canadian stocks have had significant runs.

Investorideas.com cannabis/marijuana and hemp content now also includes its http://cannabisstocknews.blogspot.com on Blogger.com, a cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site Global Cannabis Investing at www.Globalcannabisinvesting.com



Read this release in full at http://www.investorideas.com/news/2017/marijuana/04103Stocks.asp

Marijuana/Hemp Stocks Directory Preview

Featured Marijuana Stocks at Investorideas.com

SinglePoint, Inc. (OTC: SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry. www.SinglePoint.com
22nd Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company.
3DX Industries Inc. (OTC: DDDX) is focused on the additive metal manufacturing segment within the manufacturing industry. 3DX has the capability of manufacturing a wide variety of products using its 3D metal printing system, 3D composite printing as well as more traditional methods of precision manufacturing. 3DX offers additive and subtractive manufacturing options as well as product design, engineering and assembly services to its customers.  Cannabis: Has completed the development and design of a new and innovative product used for recovering excess heat from high energy grow lights. The part was designed specifically for the legalized cannabis markets including medical marijuana using the company's 3D Metal printing -- Binder Additive manufacturing process and is expected to be installed in select licensed facilities for real world testing in the coming months.
ABATTIS BIOCEUTICALS (OTC:ATTBF) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.
Acology Inc (OTC:ACOL) markets and sells the TSOS Container™ (The Science of Storage).This container is the first-ever FDA approved polypropylene air-tight, water-tight, smell-proof delivery and storage container with a built-in grinder. It is manufactured from medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching. These containers are portable and affordable. he Medtainer™ allows patients to store, grind and pour a variety of medications, including pills and all sizes and solidity, herbal medications and teas and even coffee and spices! The Medtainer™ can be ordered in with a certified child-resistant cap. Each Medtainer™ is water-proof and smell proof. Caregivers who are responsible for ensuring their patients medication regimens are universally pleased with the how easy and effective the Medtainer™ grind medications. It is an excellent solution for patients with dysphasia due to cognitive disorders or brain injuries, are in hospice or palliative situations and for anyone who would rather not swallow whole pills. The MedTainer™ was originally developed for geriatric and pediatric patients who had difficulty swallowing pills or needed an effective alternative to costly name-brand medications. The MedTainer™ has been sold and is being successfully used throughout the United States, Canada, Mexico and South America and Europe. Our association with the Medical Marijuana community was an unexpected windfall that has given Acology, Inc. the necessary funding to expand into the growing hospice and palliative care markets, and to help countless patients who are living at home or in small home-like settings and need help swallowing pills.
Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.
AeroGrow International, Inc. (OTC:AERO) Headquartered in Boulder, Colorado, AeroGrow International, Inc. is the leader in the rapidly growing indoor gardening category. AeroGardens allow anyone to grow farmer's market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, year-round, so simply and easily that no green thumb is required. With an AeroGarden... you can grow anything! In April 2013, AeroGrow entered into a strategic partnership with Scotts Miracle-Gro to continue to expand the indoor gardening market.
AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.
Agritek Holdings Inc (OTC:AGTK) a fully reporting Company and pioneer within the medicinal marijuana space provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines through its wholly-owned subsidiary, Agritek Holdings Inc.  Agritek Holdings Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.
ALGAE DYNAMICS CORP (OTCQB: ADYNF) is currently engaged in the commercialization of our proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass. This biomass is high in Omega-3s DHA/DPA, vitamins, minerals and antioxidants, all of which are in demand by the growing multibillion dollar food/beverage and health care sectors. Our integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our "controlled outcomes" technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil.
Alliance Growers Corp. (CSE:ACG) is a cannabis company dedicated to building shareholder value through its 4 Pillars business strategy. The company was incorporated in 2014 and is publicly traded on the CSE under the symbol ACG. The company’s head office is in Vancouver, BC and its interest in a marijuana production facility in Kelowna, BC.

The complete marijuana/hemp stock list available for purchase in a PDF format:
http://www.investorideas.com/dirs/stocklist.asp

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Services for Publicly traded and private companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. . Disclosure SING is a paid featured profile company for PR and news and SING and ADYNF are paid featured companies on the 420 directory www.420cannabisinvestorideas.com    

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news















Posted by at No comments:

Friday, April 7, 2017

Cannabis Crowdfunding News: HelloMD and SeedInvest Offer Cannabis Investment Opportunity to All With Live Debut at Launch Festival

Cannabis Crowdfunding News: HelloMD and SeedInvest Offer Cannabis Investment Opportunity to All With Live Debut at Launch Festival
Supporters of the marijuana industry can now invest in HelloMD as company launches considerable equity crowdfunding opportunity via SeedInvest

SAN FRANCISCO - April 7, 2017 (Investorideas.com Newswire) HelloMD, one of the nation's largest community of medical cannabis patients, experts and trusted brands, announced today that it has partnered with SeedInvest, the foremost online investing platform, opening an investment opportunity in the company to any and all interested parties. HelloMD will be accepting live investments on SeedInvest.com starting this Friday, April 7th at Launch Festival in the Innovation Hangar & Palace of Fine Arts Theatre in San Francisco.
Launch Festival, founded by Jason Calacanis and now in partnership with SeedInvest, is one of the largest startup events in the United States. Attended by over 12,000 investors and founders from around the world, Launch showcases pioneering startups from a variety of industries. SeedInvest conducts an extremely rigorous due diligence process whereby only 1% of all applicants make it on to their platform. HelloMD will be one of few startups sanctioned to raise capital in real-time during the event directly from attendees, and one of the very few representing the cannabis industry.
"We are thrilled at our partnership with SeedInvest and the opportunity this brings to all supporters of cannabis who may be looking to invest in the industry but until now were unable to do so," said Mark Hadfield, CEO and co-founder of HelloMD. "We have been working closely with SeedInvest to present this opportunity, and after undergoing a demanding vetting process are eager to bring the investment live."
Following decades of prohibition, attitudes towards cannabis are rapidly changing. According to Forbes, the legal cannabis market was worth an estimated $7.2 billion in 2016 and is projected to grow at a compound annual rate of 17%. Total market growth is predicted to exceed $24 billion by 2020.
"As the old stereotypes and back alley transactions fade away, new cannabis products are appearing and new professional operations are stepping in making cannabis one of the fastest growing and hottest markets to invest in," said Hadfield. "But, if you're an individual investor, your options to invest, until now, have been very limited."
About HelloMD
HelloMD is one of the nation's largest virtual community of medical cannabis patients, experts and trusted brands. Medical cannabis consumers from across the globe can ask questions online, get answers quickly from doctors and experts, or research cannabis solutions from leading product manufacturers. The platform also provides its members easy, convenient online video access to physicians (daily, 10:00 a.m. – 7:00 p.m. (PST)) for medical cannabis consultations, recommendations to qualifying patients, product advice and more. For more information about HelloMD, or to join its 150K-member community, visit www.hellomd.com or follow us on Facebook (@HelloMDcompany) and Twitter (@HelloMD_com).
About SeedInvest
SeedInvest is a leading equity crowdfunding platform that provides high-quality startup investment opportunities to investors who haven't previously had access to them. SeedInvest was founded in 2012 by former professional investors Ryan Feit and James Han and is located in the heart of New York City's entrepreneurial community. For more information please go to www.seedinvest.com and follow us on Twitter @seedinvest_co.
HelloMD is offering securities under Regulation CF and Rule 506(c) of Regulation D through SI Securities, LLC ("SI Securities"). The Company has filed a Form C with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here https://www.seedinvest.com/hellomd/series.a.
Media Contacts
Jennifer Price / Michael Litchfield
T: 609-638-2558 / 415-793-6618
E: 154150@email4pr.com
SOURCE HelloMD
Related Links https://www.hellomd.com


More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Posted by at No comments:
Subscribe to: Posts (Atom)